Nature's Toolbox is advancing the healthcare industry with their next generation biomanufacturing solutions. NTx, based in Rio Rancho, New Mexico, is developing innovative systems like NTxpress® and NTxscribe® to enable manufacturing of mRNA vaccines and protein therapeutics in an eco-friendly and sustainable way. These easily scalable processes enable NTx's platform to scale from personalized medicine dosage to pandemic volume.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/17/23 | $47,500,000 | Series B |
RA Capital Management | undisclosed |
